Your browser doesn't support javascript.
loading
ß1 integrin monoclonal antibody treatment ameliorates cerebral cavernous malformations.
McCurdy, Sara; Lin, Jenny; Shenkar, Robert; Moore, Thomas; Lightle, Rhonda; Faurobert, Eva; Lopez-Ramirez, Miguel-Alejandro; Awad, Issam; Ginsberg, Mark H.
  • McCurdy S; Department of Medicine, University of California San Diego, La Jolla, California, USA.
  • Lin J; Department of Medicine, University of California San Diego, La Jolla, California, USA.
  • Shenkar R; Department of Neurological Surgery, University of Chicago, Chicago, Illinois, USA.
  • Moore T; Department of Neurological Surgery, University of Chicago, Chicago, Illinois, USA.
  • Lightle R; Department of Neurological Surgery, University of Chicago, Chicago, Illinois, USA.
  • Faurobert E; Institute for Advanced Biosciences, Inserm 1209, CNRS 5309, Université de Grenoble Alpes, Grenoble, France.
  • Lopez-Ramirez MA; Department of Medicine, University of California San Diego, La Jolla, California, USA.
  • Awad I; Department of Pharmacology, University of California, San Diego, La Jolla, California, USA.
  • Ginsberg MH; Department of Neurological Surgery, University of Chicago, Chicago, Illinois, USA.
FASEB J ; 36(12): e22629, 2022 12.
Article en En | MEDLINE | ID: mdl-36349990
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Hemangioma Cavernoso del Sistema Nervioso Central Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Hemangioma Cavernoso del Sistema Nervioso Central Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Año: 2022 Tipo del documento: Article